|
| |
xcyte therapies Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioSpace - Xcyte Therapies, Inc. News, Search Jobs, Events
Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock 10/19/2005 5:13:16 PM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=2876...
|
BioPortfolio - Xcyte Therapies Incorporated
Xcyte Therapies Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/11082-Xcyte_Therapi...
|
Molecular Therapy - Abstract of article: 707. Transduction and ...
... Memorial Sloan Kettering Cancer Center, New York, NY; 3Xcyte Therapies, ... Significantly, the biologic activity of the T cells activated with Xcyte ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005827a.html...
|
BioPortfolio - xcyte founder
BioPortfolio - xcyte founder Xcyte Therapies has an experienced ... Inc. He previously served as a director for Xcyte Therapies, Inc. before its . ...
http://www.bioportfolio.com/search/xcyte_founder.html...
|
Molecular Therapy - Abstract of article: 709. Comparison of the ...
|[ast]|MLB is an employee of Xcyte Therapies, Inc., and has equity (stock) interests in Xcyte Therapies, Inc. Top of page ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005829a.html...
|
BioPortfolio - xcyte therapeutics,
BioPortfolio - xcyte therapeutics, Xcyte Therapies Inc announces withdrawal of . ... Bioportfolio - Xcyte Therapies Incorporated BioTools Incorporated . ...
http://www.bioportfolio.com/search/xcyte_therapeutics,.html...
|
Molecular Therapy - Abstract of article: 810. Ex-Vivo Activation ...
1Oncology, Washington University School of Medicine, Saint Louis, MO; 2Xcyte Therapies, Inc., Seattle, WA. |[ast]|MB is an employee of Xcyte Therapies, ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005930a.html...
|
Molecular Therapy - Abstract of article: 707. Transduction and ...
... Memorial Sloan Kettering Cancer Center, New York, NY; 3Xcyte Therapies, ... initially activated with Xcyte Dynabeads range from 58% to 80% 19-28z+ T ...
https://secure.nature.com/mt/journal/v11/n1s/abs/mt2005827a....
|
Molecular Therapy - Abstract of article: 288. A System for GMP ...
T cell stimulation was done using clinical grade magnetic beads coated with CD3 and CD28 antibodies (Xcyte Therapies, Inc., Seattle, WA). ...
http://www.nature.com/mt/journal/v11/n1s/abs/mt2005408a.html...
|
BioPortfolio - GenPhar, Inc
http://www.bioportfolio.com/search/Genphar.html... BioPortfolio - BioTools Incorporated BioPortfolio - xcyte therapeutics, Xcyte Therapies Inc announces .
...
http://www.bioportfolio.com/search/GenPhar,_Inc.html...
|
|
